arecoline has been researched along with Demyelinating Diseases in 1 studies
Arecoline: An alkaloid obtained from the betel nut (Areca catechu), fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetylcholine receptors. It is used in the form of various salts as a ganglionic stimulant, a parasympathomimetic, and a vermifuge, especially in veterinary practice. It has been used as a euphoriant in the Pacific Islands.
arecoline : A tetrahydropyridine that is 1,2,5,6-tetrahydropyridine with a methyl group at position 1, and a methoxycarbonyl group at position 3. An alkaloid found in the areca nut, it acts as an agonist of muscarinic acetylcholine.
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
Excerpt | Relevance | Reference |
---|---|---|
"Cerebral demyelination is possibly one of the main pathological factors involved in the development of schizophrenia." | 5.51 | Arecoline attenuates memory impairment and demyelination in a cuprizone-induced mouse model of schizophrenia. ( Adilijiang, A; He, J; Li, X; Lin, D; Wang, W; Xu, Z; You, P, 2019) |
"Cerebral demyelination is possibly one of the main pathological factors involved in the development of schizophrenia." | 1.51 | Arecoline attenuates memory impairment and demyelination in a cuprizone-induced mouse model of schizophrenia. ( Adilijiang, A; He, J; Li, X; Lin, D; Wang, W; Xu, Z; You, P, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Xu, Z | 1 |
Adilijiang, A | 1 |
Wang, W | 1 |
You, P | 1 |
Lin, D | 1 |
Li, X | 1 |
He, J | 1 |
1 other study available for arecoline and Demyelinating Diseases
Article | Year |
---|---|
Arecoline attenuates memory impairment and demyelination in a cuprizone-induced mouse model of schizophrenia.
Topics: Animals; Arecoline; Chelating Agents; Cholinergic Agonists; Cuprizone; Demyelinating Diseases; Disea | 2019 |